Polyphosphate: A Conserved Modifier of Amyloidogenic Processes

Molecular Cell

Volumn 63, Issue 5, 2016, Pages 768-780

  Cremers, Claudia M ^a   Knoefler, Daniela ^a   Gates, Stephanie ^a,b   Martin, Nicholas ^a   Dahl, Jan Ulrik ^a   Lempart, Justine ^a   Xie, Lihan ^a   Chapman, Matthew R ^a   Galvan, Veronica ^c   Southworth, Daniel R ^a,b   Jakob, Ursula ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PROTEIN; POLYPHOSPHATE; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); CSGA PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; MAPT PROTEIN, HUMAN; PEPTIDE FRAGMENT; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAENORHABDITIS ELEGANS; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NEUROBLASTOMA; NONHUMAN; PROTEIN STABILITY; UROPATHOGENIC ESCHERICHIA COLI; AGONISTS; ANIMAL; BIOFILM; CHEMISTRY; DRUG EFFECTS; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; GROWTH, DEVELOPMENT AND AGING; KINETICS; METABOLISM; NERVE CELL; PATHOLOGY; PROTEIN FOLDING; TRANSGENIC ANIMAL; TUMOR CELL LINE;

ALPHA-SYNUCLEIN; AMYLOID BETA-PEPTIDES; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BIOFILMS; CAENORHABDITIS ELEGANS; CELL LINE, TUMOR; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; GENE EXPRESSION; HUMANS; KINETICS; NEURONS; PEPTIDE FRAGMENTS; POLYPHOSPHATES; PROTEIN FOLDING; TAU PROTEINS;

EID: 84992454902     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2016.07.016     Document Type: Article

References (34)

1. Chen, S.W., Drakulic, S., Deas, E., Ouberai, M., Aprile, F.A., Arranz, R., Ness, S., Roodveldt, C., Guilliams, T., De-Genst, E.J., et al. Structural characterization of toxic oligomers that are kinetically trapped during α-synuclein fibril formation. Proc. Natl. Acad. Sci. USA 112 (2015), E1994–E2003.
2. Cohlberg, J.A., Li, J., Uversky, V.N., Fink, A.L., Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry 41 (2002), 1502–1511.
3. Cremades, N., Cohen, S.I., Deas, E., Abramov, A.Y., Chen, A.Y., Orte, A., Sandal, M., Clarke, R.W., Dunne, P., Aprile, F.A., et al. Direct observation of the interconversion of normal and toxic forms of α-synuclein. Cell 149 (2012), 1048–1059.
4. Datsenko, K.A., Wanner, B.L., One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97 (2000), 6640–6645.
5. Desplats, P., Lee, H.J., Bae, E.J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., Lee, S.J., Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. USA 106 (2009), 13010–13015.
6. Eichner, T., Radford, S.E., A diversity of assembly mechanisms of a generic amyloid fold. Mol. Cell 43 (2011), 8–18.
7. Emmanouilidou, E., Melachroinou, K., Roumeliotis, T., Garbis, S.D., Ntzouni, M., Margaritis, L.H., Stefanis, L., Vekrellis, K., Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival. J. Neurosci. 30 (2010), 6838–6851.
8. Galvin, J.E., Lee, V.M., Trojanowski, J.Q., Synucleinopathies: clinical and pathological implications. Arch. Neurol. 58 (2001), 186–190.
9. Giehm, L., Lorenzen, N., Otzen, D.E., Assays for α-synuclein aggregation. Methods 53 (2011), 295–305.
10. Goedert, M., Jakes, R., Spillantini, M.G., Hasegawa, M., Smith, M.J., Crowther, R.A., Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383 (1996), 550–553.
11. Gray, M.J., Wholey, W.Y., Wagner, N.O., Cremers, C.M., Mueller-Schickert, A., Hock, N.T., Krieger, A.G., Smith, E.M., Bender, R.A., Bardwell, J.C., Jakob, U., Polyphosphate is a primordial chaperone. Mol. Cell 53 (2014), 689–699.
12. Hefti, F., Goure, W.F., Jerecic, J., Iverson, K.S., Walicke, P.A., Krafft, G.A., The case for soluble Aβ oligomers as a drug target in Alzheimer's disease. Trends Pharmacol. Sci. 34 (2013), 261–266.
13. Hegde, M.L., Rao, K.S.J., DNA induces folding in alpha-synuclein: understanding the mechanism using chaperone property of osmolytes. Arch. Biochem. Biophys. 464 (2007), 57–69.
14. Holmström, K.M., Marina, N., Baev, A.Y., Wood, N.W., Gourine, A.V., Abramov, A.Y., Signalling properties of inorganic polyphosphate in the mammalian brain. Nat. Commun., 4, 2013, 1362.
15. Hsia, A.Y., Masliah, E., McConlogue, L., Yu, G.Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R.C., Nicoll, R.A., Mucke, L., Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl. Acad. Sci. USA 96 (1999), 3228–3233.
16. Hufnagel, D.A., Tükel, C., Chapman, M.R., Disease to dirt: the biology of microbial amyloids. PLoS Pathog., 9, 2013, e1003740.
17. Ingelsson, M., Fukumoto, H., Newell, K.L., Growdon, J.H., Hedley-Whyte, E.T., Frosch, M.P., Albert, M.S., Hyman, B.T., Irizarry, M.C., Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62 (2004), 925–931.
18. Iwai, A., Masliah, E., Yoshimoto, M., Ge, N., Flanagan, L., de Silva, H.A., Kittel, A., Saitoh, T., The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system. Neuron 14 (1995), 467–475.
19. Kornberg, A., Rao, N.N., Ault-Riché, D., Inorganic polyphosphate: a molecule of many functions. Annu. Rev. Biochem. 68 (1999), 89–125.
20. Kumble, K.D., Kornberg, A., Inorganic polyphosphate in mammalian cells and tissues. J. Biol. Chem. 270 (1995), 5818–5822.
21. Litvinov, R.I., Faizullin, D.A., Zuev, Y.F., Weisel, J.W., The α-helix to β-sheet transition in stretched and compressed hydrated fibrin clots. Biophys. J. 103 (2012), 1020–1027.
22. Lorenz, B., Münkner, J., Oliveira, M.P., Kuusksalu, A., Leitão, J.M., Müller, W.E., Schröder, H.C., Changes in metabolism of inorganic polyphosphate in rat tissues and human cells during development and apoptosis. Biochim. Biophys. Acta 1335 (1997), 51–60.
23. 1−42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer's disease. Mol. Neurodegener., 7, 2012, 57.
24. Morrissey, J.H., Polyphosphate: a link between platelets, coagulation and inflammation. Int. J. Hematol. 95 (2012), 346–352.
25. Mucke, L., Masliah, E., Yu, G.Q., Mallory, M., Rockenstein, E.M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., McConlogue, L., High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20 (2000), 4050–4058.
26. Müller, F., Mutch, N.J., Schenk, W.A., Smith, S.A., Esterl, L., Spronk, H.M., Schmidbauer, S., Gahl, W.A., Morrissey, J.H., Renné, T., Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell 139 (2009), 1143–1156.
27. Munishkina, L.A., Fink, A.L., Uversky, V.N., Accelerated fibrillation of alpha-synuclein induced by the combined action of macromolecular crowding and factors inducing partial folding. Curr. Alzheimer Res. 6 (2009), 252–260.
28. Rao, N.N., Gómez-García, M.R., Kornberg, A., Inorganic polyphosphate: essential for growth and survival. Annu. Rev. Biochem. 78 (2009), 605–647.
29. Rashid, M.H., Rumbaugh, K., Passador, L., Davies, D.G., Hamood, A.N., Iglewski, B.H., Kornberg, A., Polyphosphate kinase is essential for biofilm development, quorum sensing, and virulence of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 97 (2000), 9636–9641.
30. Roberts, H.L., Brown, D.R., Seeking a mechanism for the toxicity of oligomeric α-synuclein. Biomolecules 5 (2015), 282–305.
31. Sakatani, A., Fujiya, M., Ueno, N., Kashima, S., Sasajima, J., Moriichi, K., Ikuta, K., Tanabe, H., Kohgo, Y., Polyphosphate Derived from Lactobacillus brevis Inhibits Colon Cancer Progression Through Induction of Cell Apoptosis. Anticancer Res. 36 (2016), 591–598.
32. Selkoe, D.J., Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81 (2001), 741–766.
33. Tipping, K.W., Karamanos, T.K., Jakhria, T., Iadanza, M.G., Goodchild, S.C., Tuma, R., Ranson, N.A., Hewitt, E.W., Radford, S.E., pH-induced molecular shedding drives the formation of amyloid fibril-derived oligomers. Proc. Natl. Acad. Sci. USA 112 (2015), 5691–5696.
34. Wang, L., Fraley, C.D., Faridi, J., Kornberg, A., Roth, R.A., Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells. Proc. Natl. Acad. Sci. USA 100 (2003), 11249–11254.